These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 3494084

  • 1. Induction of NK cell activity against fresh human leukemia in culture with interleukin 2.
    Lotzová E, Savary CA, Herberman RB.
    J Immunol; 1987 Apr 15; 138(8):2718-27. PubMed ID: 3494084
    [Abstract] [Full Text] [Related]

  • 2. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW, Shamim F, Hamon M, Macdonald ID, Prentice HG.
    Exp Hematol; 1995 Dec 15; 23(14):1530-4. PubMed ID: 8542943
    [Abstract] [Full Text] [Related]

  • 3. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ.
    Clin Cancer Res; 1998 Nov 15; 4(11):2859-68. PubMed ID: 9829753
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunologic and clinical aspects of natural killer cells in human leukemia.
    Lotzová E, Savary CA, Pollock RE, Fuchshuber P.
    Nat Immun Cell Growth Regul; 1990 Nov 15; 9(3):173-81. PubMed ID: 2370877
    [Abstract] [Full Text] [Related]

  • 6. Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission.
    Torelli GF, Guarini A, Maggio R, Alfieri C, Vitale A, Foà R.
    Haematologica; 2005 Jun 15; 90(6):785-92. PubMed ID: 15951291
    [Abstract] [Full Text] [Related]

  • 7. Generation of NK cell activity from human bone marrow.
    Lotzová E, Savary CA.
    J Immunol; 1987 Jul 01; 139(1):279-84. PubMed ID: 3495600
    [Abstract] [Full Text] [Related]

  • 8. Enrichment of oncolytic cells for adoptive therapy using centrifugal elutriation.
    Savary CA, Lotzová E, Lichtiger B, Freireich EJ.
    J Clin Lab Immunol; 1990 Jul 01; 32(3):123-9. PubMed ID: 1966948
    [Abstract] [Full Text] [Related]

  • 9. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
    Vose BM, Bonnard GD.
    J Immunol; 1983 Feb 01; 130(2):687-93. PubMed ID: 6600251
    [Abstract] [Full Text] [Related]

  • 10. Comparison of natural killer activity of human bone marrow and blood cells in cultures containing IL-2, IL-7 and IL-12.
    Wong EK, Eaves C, Klingemann HG.
    Bone Marrow Transplant; 1996 Jul 01; 18(1):63-71. PubMed ID: 8831997
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T, Belfrage H, Bhiladvala P, Hedlund G.
    J Immunol; 1987 Jun 01; 138(11):3640-5. PubMed ID: 3495566
    [Abstract] [Full Text] [Related]

  • 14. Design and validation of a clinically applicable culture procedure for the generation of interleukin-2 activated natural killer cells in human bone marrow autografts.
    Klingemann HG, Deal H, Reid D, Eaves CJ.
    Exp Hematol; 1993 Aug 01; 21(9):1263-70. PubMed ID: 8330650
    [Abstract] [Full Text] [Related]

  • 15. A novel approach to purging of leukemia by activation of bone marrow with interleukin 2.
    Charak BS, Malloy B, Agah R, Mazumder A.
    Bone Marrow Transplant; 1990 Sep 01; 6(3):193-8. PubMed ID: 2252959
    [Abstract] [Full Text] [Related]

  • 16. High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2.
    Uharek L, Zeis M, Glass B, Steinmann J, Dreger P, Gassmann W, Schmitz N, Müller-Ruchholtz W.
    Leukemia; 1996 Nov 01; 10(11):1758-64. PubMed ID: 8892679
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity.
    Kaufmann Y, Levanon M, Davidsohn J, Ramot B.
    J Immunol; 1987 Aug 01; 139(3):977-82. PubMed ID: 3496395
    [Abstract] [Full Text] [Related]

  • 19. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J, Broxmeyer HE.
    Cell Immunol; 1997 Sep 15; 180(2):132-42. PubMed ID: 9341743
    [Abstract] [Full Text] [Related]

  • 20. Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth.
    Lotzová E, Savary CA.
    Nat Immun; 1993 Sep 15; 12(4-5):209-17. PubMed ID: 8257827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.